UNITED STATES
SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549

FORM 10-QSB

(Mark One)x Quarterly Report Pursuant To Section 13 Or 15(d) Of The Securities Exchange Act Of 1934

For the quarterly period ended March 31,  2008

 ̈Transition Report Under Section 13 Or 15(d) Of The Securities Exchange Act Of 1934

For the transition period ________ to ________

COMMISSION FILE NUMBER 000-51698

QV, QUANTUM VENTURES, INC.(Exact name of small business issuer as specified in its charter)

|NEVADA                                   | Applied for              
|---------------------------------------- | -------------------------
|                                         | IRS Identification Number
|organization)                            |                          
|                                         |                          
|16 Midlake Boulevard , Suite 312        
|SE Calgary AB, Canada T2X 2X7           
|(Address of principal executive offices)
|(403 397-7211                           
|Issuer's telephone number               
|                                        

Quantum Ventures, Inc.

(Former name, former address and former fiscal year, if changed since last report)

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the 
Exchange Act during the past twelve months (or for such shorter period that the registrant was required 
to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YesxNo  ̈

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the 
Exchange Act). Yes  ̈ Nox

State the number of shares outstanding of each of the issuer's classes of common equity, as of the 
latest practicable date: As of March 31, 2008, the Issuer had, 14,650,000 Shares of Common 
Stock outstanding.

Transitional Small Business Disclosure Format (check one): Yes  ̈ Nox







PART I - FINANCIAL INFORMATION

ITEM 1.          FINANCIAL STATEMENTS.

|QV, QUANTUM VENTURES, INC.   
|-----------------------------
|(A Development Stage Company)
|                             
|BALANCE SHEET                
|                             



|                                    
|------------------------------------
|                                    
|                                    
|                                    
|ASSETS                              
|Current Assets                      
|                                    
|                                    
|                                    
|                                    
|                                    
|                                    
|LIABILITIES AND STOCKHOLDERS' EQUITY
|                                    
|Current Liabilities                 
|                                    
|                                    
|                                    
|                                    
|                                    
|Stockholders' Equity                
|                                    
|                                    
|                                    
|                                    
|                                    
|                                    
|                                    
|                                    
|                                    
|                                    





See accompanying notes

F-1

































|QV,  QUANTUM VENTURES, INC.  
|-----------------------------
|(A Development Stage Company)
|                             
|STATEMENTS OF OPERATIONS     
|                             



|                                             |                                     |                          |            | For  the Three | For the Three | For the Nine                          | For the Nine                       | For the Period   
|-------------------------------------------- | ----------------------------------- | ------------------------ | ---------- | -------------- | ------------- | ------------------------------------- | ---------------------------------- | -----------------
|                                             |                                     |                          |            | Months Ended   | Months Ended  | Months Ended                          | Months Ended                       | from April 14,   
|                                             |                                     |                          |            | March 31,      | March 31,     | March 31,                             | March 31,                          | 2004 (inception) 
|                                             |                                     |                          |            | 2008           | 2007          | 2008                                  | 2007                               | to March 31, 2008
|REVENUES                                     |                                     | -                        | -          | -              | -             | $                                   -
|                                             |                                     |                          |            |                |               |                                       |                                    |                  
|OPERATING EXPENSES                           |                                     |                          |            |                |              
|                                             |                                     |                          |            |                |               |                                       |                                    |                  
|                                             | General and administrative expenses | 2,269                    | 19         | 7,996          | 4,123         | 99,719                               
|                                             |                                     |                          |            |                |               |                                       |                                    |                  
|                                             |                                     | Total operating expenses | 2,269      | 19             | 7,996         | 4,123                                 | 99,719                            
|                                             |                                     |                          |            |                |               |                                       |                                    |                  
|Net loss before provision for income taxes   | (2,269)                             | (19)                     | (7,996)    | (4,123)        | (99,719)     
|                                             |                                     |                          |            |                |               |                                       |                                    |                  
|Provision for income taxes                   | -                                   | -                        | -          | -              | -            
|                                             |                                     |                          |            |                |               |                                       |                                    |                  
|Net loss                                     |                                     |                          | (2,269)    | (19)           | (7,996)       | (4,123)                               | $                         (99,719)
|                                             |                                     |                          |            |                |               |                                       |                                    |                  
|Weighted average common shares outstanding - |                                     |                          |            |                |              
|                                             | Basic and diluted                   |                          | 14,650,000 | 14,650,000     | 14,650,000    | 14,650,000                            |                                   
|                                             |                                     |                          |            |                |               |                                       |                                    |                  
|Net loss per share  basic and diluted       | (0.00)                              | (0.00)                   | (0.00)     | (0.00)         |              
|                                             |                                     |                          |            |                |               |                                       |                                    |                  















See accompanying notes





F-2







|QV, QUANTUM VENTURES, INC.   
|-----------------------------
|(A Development Stage Company)
|                             
|STATEMENTS OF CASH FLOWS     
|                             



|                                                  |                                                    |                                       |                               |                                       |                                   | For the Nine                        | For the Nine                 | For the Period  
|------------------------------------------------- | -------------------------------------------------- | ------------------------------------- | ----------------------------- | ------------------------------------- | --------------------------------- | ----------------------------------- | ---------------------------- | ----------------
|                                                  |                                                    |                                       |                               |                                       |                                   | Months Ended                        | Months Ended                 | from April 14,  
|                                                  |                                                    |                                       |                               |                                       |                                   | March 31,                           | March 31,                    | 2004 (inception)
|                                                  |                                                    |                                       |                               |                                       |                                   | 2008                                | 2007                         | to March 31,    
|                                                  |                                                    |                                       |                               |                                       |                                   |                                     |                              | 2008            
|Cash Flows From Operating Activities              |                                                    |                                       |                               |                                      
|                                                  | Net loss                                           |                                       |                               |                                       | $                         (7,996) | $                     (4,123)       | $                   (99,970)
|                                                  |                                                    | Impairment of intangible asset        |                               | -                                     | -                                 | 6,000                              
|                                                  | Changes in current assets and current liabilities: |                                       |                              
|                                                  |                                                    | Accounts payable and accrued expenses | 3,500                         | (13,500)                              | 12,500                           
|                                                  |                                                    | Technology purchase payable           |                               | -                                     | -                                 | -                                  
|                                                  |                                                    |                                       |                               |                                       |                                   |                                     |                              |                 
|Net Cash Used In Operating Activities             |                                                    | (4,496)                               | (17,623)                      | (81,470)                             
|                                                  |                                                    |                                       |                               |                                       |                                   |                                     |                              |                 
|Cash Flows From Investing Activities              |                                                    |                                       |                               |                                      
|                                                  | Payment for technology rights                      |                                       |                               | -                                     | (10,000)                          | (15,000)                           
|                                                  |                                                    |                                       |                               |                                       |                                   |                                     |                              |                 
|Net Cash Used In Investing Activities             |                                                    | -                                     | (10,000)                      | (15,000)                             
|                                                  |                                                    |                                       |                               |                                       |                                   |                                     |                              |                 
|Cash Flows From Financing Activities:             |                                                    |                                       |                               |                                      
|                                                  | Proceeds from related party loan                   |                                       | 4,000                         |                                       | 4,000                            
|                                                  | Proceeds from the issuance of common stock         | -                                     | -                             | 92,500                               
|                                                  |                                                    |                                       |                               |                                       |                                   |                                     |                              |                 
|Net Cash Provided By Financing Activities         |                                                    | 4,000                                 | -                             | 96,500                               
|                                                  |                                                    |                                       |                               |                                       |                                   |                                     |                              |                 
|Increase (decrease)  in Cash and Cash Equivalents | (496)                                              | (27,623)                              | 30                           
|                                                  |                                                    |                                       |                               |                                       |                                   |                                     |                              |                 
|Cash and Cash Equivalents, Beginning of Period    |                                                    | 549                                   | 39,678                        | -                                    
|                                                  |                                                    |                                       |                               |                                       |                                   |                                     |                              |                 
|Cash and Cash Equivalents, End of Period          |                                                    | $                                 30  | $                      12,055 | $                              30    
|                                                  |                                                    |                                       |                               |                                       |                                   |                                     |                              |                 
|Supplemental Disclosure of Cash Flow Information: |                                                    |                                      
|                                                  |                                                    |                                       |                               |                                       |                                   |                                     |                              |                 
|                                                  | Cash paid for interest                             |                                       |                               | $                                  -  | $                               - | $                                 -
|                                                  | Cash paid for income taxes                         |                                       |                               | $                                   - | $                               - | $                                 -
|                                                  |                                                    |                                       |                               |                                       |                                   |                                     |                              |                 



See accompanying notes

F-3

































|QV, QUANTUM VENTURES, INC.          
|------------------------------------
|(A Development Stage Company)       
|NOTES TO THE FINANCIAL STATEMENTS   
|(Expressed in United States Dollars)
|March 31, 2008                      
|Unaudited                           



NOTE 1 - NATURE OF OPERATIONS



Organization



QV, Quantum Ventures, Inc. (the Company) was incorporated in Nevada on April 14, 2004.  The Company is a development stage company engaged in the business of commercializing the development of office system software.



Interim Reporting



While the information presented in the accompanying interim three and nine months financial statements is unaudited, it includes all adjustments, which are, in the opinion of management, necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented in accordance with accounting principles generally accepted in the United States of America.  These interim financial statements follow the same accounting policies and methods of their application as the June 30, 2007 audited annual financial statements of Quantum Ventures, Inc.  All adjustments are of a normal recurring nature. It is suggested that these interim financial statements be read in conjunction with the Companys audited June 30, 2007 annual financial statements.



Operating results for the three months and nine months ended March 31, 2008 are not necessarily indicative of the results that can be expected for the year ended June 30, 2008.



NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES



Recent Accounting Pronouncements



Recent accounting pronouncements that the Company has adopted or will be required to adopt in the future are summarized below.



In September 2006, the FASB issued SFAS No. 157, "Fair Value Measurements" (SFAS 157). SFAS 157 provides guidance for using fair value to measure assets and liabilities. SFAS 157 addresses the requests from investors for expanded disclosure about the extent to which companies measure assets and liabilities at fair value, the information used to measure fair value and the effect of fair value measurements on earnings. SFAS 157 applies whenever other standards require (or permit) assets or liabilities to be measured at fair value, and does not expand the use of fair value in any new circumstances. SFAS 157 is effective for financial statements issued for fiscal years beginning after November 15, 2007 and will be adopted by the Company in the first quarter of fiscal year 2009. The Company is unable at this time to determine the effect that its adoption of SFAS 157 will have on its consolidated results of operations and financial condition.











F-4





|QV, QUANTUM VENTURES, INC.          
|------------------------------------
|A Development Stage Company)        
|NOTES TO THE FINANCIAL STATEMENTS   
|(Expressed in United States Dollars)
|March 31, 2008                      



NOTE 2-SIGNIFICANT ACCOUNTING POLICIES (Continued)



In February 2007, the Financial Accounting Standards Board (FASB) issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities - Including an amendment of FASB Statement No. 115 (SFAS No. 159). SFAS No. 159 allows companies to choose to measure many financial instruments and certain other items at fair value. SFAS No. 159 will become effective for the Company beginning in fiscal 2009. The Company is currently evaluating what effects the adoption of SFAS No. 159 will have on the Companys future results of operations and financial condition.



In December, 2007, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards (SFAS) No. 141 (revised 2007), Business Combinations (hereinafter SFAS No. 141 (revised 2007)). This statement establishes principles and requirements for how an acquirer a) recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed and any noncontrolling interest in the acquiree, b) recognizes and measures the goodwill acquired in the business combination or a gain from a bargain purchase and c) determines what information to disclose to enable users of the financial statements to evaluate the nature and financial effects of the business combination. The scope of SFAS No. 141 (revised 2007) is broader than the scope of SFAS No. 141, which it replaces. The effective date of SFAS No. 141 (revised 2007) is for all acquisitions in which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2008. The adoption of this statement has no immediate material effect on the Companys consolidated financial condition or results of operations.



In December, 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in Consolidated Financial Statements  an amendment of ARB No. 51 (hereinafter SFAS No. 160). This statement establishes accounting and reporting standards that require a) the ownership interests in subsidiaries held by parties other than the parent be clearly identified, labeled and presented in the consolidated statement of financial position with equity, but separate from the parents equity, b) the amount of consolidated net income attributable to the parent and to the noncontrolling interest be clearly identified and presented on the face of the consolidated statement of income, c) changes in a parents ownership interest while the parent retains its controlling financial interest in its subsidiary be accounted for consistently, d) when a subsidiary is deconsolidated, any retained noncontrolling  equity investment in the former subsidiary be initially measured at fair value and e) entities provide sufficient disclosures that clearly identify and distinguish between the interests of the parent and the interests of the noncontrolling owners. The effective date of this standard is for fiscal years and interim periods beginning on or after December 15, 2008. The adoption of this statement had no immediate material effect on the Companys consolidated financial condition or results of operations.













F-5



|QV, QUANTUM VENTURES, INC.          
|------------------------------------
|(A Development Stage Company)       
|NOTES TO THE FINANCIAL STATEMENTS   
|(Expressed in United States Dollars)
|March 31, 2008                      
|Unaudited                           



NOTE 2-SIGNIFICANT ACCOUNTING POLICIES (Continued)



In March 2008, the FASB issued SFAS No. 161, Disclosure about Derivative Instruments and Hedging Activities, an amendment of FASB Statement No. 133, (SFAS 161). This statement requires that objectives for using derivative instruments be disclosed in terms of underlying risk and accounting designation. The Company is required to adopt SFAS 161 on January 1, 2009. The Company is currently evaluating the potential impact of SFAS No. 161 on the Companys consolidated financial statements.

In April 2008, the FASB issued FSP FAS 142-3, Determination of the Useful Life of Intangible Assets,, which amends the factors that should be considered in developing renewal or extension assumptions used to determine the useful life of intangible assets  under FASB 142 Goodwill and Other Intangible Assets.  The intent of this FSP is to improve the consistency between the useful life of a recognized intangible asset under SFAS 142 and the period of the expected cash flows used to measure the fair value of the asset under FASB 141 (revised 2007) Business Combinations and other U.S. generally accepted accounting principles.    The Company is currently evaluating the potential impact of FSP FAS 142-3 on its consolidated financial statements.



NOTE 3  TECHNOLOGY PURCHASE AGREEMENT PAYABLE



By an agreement dated May 18, 2004 the Company purchased software, known as Mediflow in consideration of payment to the Vendor of $5,000 and 100,000 common shares of the Company.  In addition, the Company will grant the vendor a 2% royalty on net sales of any product that uses any portion of the technology.   The agreement was subsequently amended and calls for the cancellation of the 100,000 common shares, the sum of $3,000 payable upon execution of the agreement, and a non-refundable sum of $10,000 paid on August 22, 2006.  As of March 31, 2008, there is no balance due.



NOTE 4  COMMON STOCK



On January 18, 2008 the Board of Directors of the registrant passed unanimously a resolution authorizing a forward split of the authorized and issued and outstanding common shares on a eight to one (8  1) basis bringing the total common shares issued and outstanding to 117,200,000 and authorized common shares to 400,000,000



















F-6



|QV, QUANTUM VENTURES, INC.          
|------------------------------------
|(A Development Stage Company)       
|NOTES TO THE FINANCIAL STATEMENTS   
|(Expressed in United States Dollars)
|March 31, 2008                      
|Unaudited                           



NOTE 5 RELATED PARTY LOAN



On October 16, 2007 the company received $4,000 cash from a shareholder loan to continue its operations. The loan is funded by the President and non interest bearing.



NOTE 6-SUBSUQUENT EVENTS

On April 15, 2008, QV, Quantum Ventures, Inc. (the "Registrant") entered into a License agreement (The Agreement) with Canadian Integrated Optics International Ltd. of Douglas, Isle of Man (CIOI), to manufacture and market CIOIs  patent  pending solar technology based on an optical rectenna. Closing of this agreement will occur on or about   May 16, 2008 and is subject to certain terms and conditions.  The Purchase Price for the license shall be paid in shares of the Companys common stock and a 5% royalty.

































































F-7





ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.

Cautionary Statement Regarding Forward-Looking Statements

Certain statements contained in this Quarterly Report constitute "forward-looking statements". These statements, identified by words such as plan, "anticipate," "believe," "estimate," "should," "expect" and similar expressions, include our expectations and objectives regarding our future financial position, operating results and business strategy. These statements reflect the current views of management with respect to future events and are subject to risks, uncertainties and other factors that may cause our actual results, performance or achievements, or industry results, to be materially different from those described in the forward-looking statements. Such risks and uncertainties include those set forth under this caption "Management's Discussion and Analysis or Plan of Operation" and elsewhere in this Quarterly Report. We do not intend to update the forward-looking information to reflect actual results or changes in the factors affecting such forward-looking information. We advise you to carefully review the reports and documents we file from time to time with the Securities and Exchange Commission (the SEC).

As used in this Quarterly Report, the terms "we", "us", "our", the Company and Quantum mean (QV) Quantum Ventures, Inc. unless otherwise indicated. All dollar amounts in this Quarterly Report are in U.S. dollars unless otherwise stated.

Introduction

The following discussion and analysis summarizes our plan of operation for the next twelve months, our results of operations for the three-month period ended March 31, 2008. This discussion should be read in conjunction with the Managements Discussion and Analysis or Plan of Operation.

(QV) Quantum Ventures, Inc. formerly Quantum Ventures, Inc. is a corporation formed under the laws of the State of Nevada on, April 14, 2004 whose principal executive offices are located in Calgary Alberta, Canada. Our principal business is the development, marketing and of a software product called Mediflow.

About Our Business

We are a development stage company.  We have produced no revenues to date, and have not begun revenue producing activities.  We have had extremely limited operations and have relied on the sale of our securities and loans or capital infusions from our officers and directors to fund our operations to date. Our auditors have included in their report covering our financial statements for the period from incorporation to June 30, 2006, that there is substantial doubt about our ability to continue as a going concern. Our business plan is to further develop and commercialize the MediFlow Software Program, a medical tracking software program that will assist healthcare professionals in diagnosing and recommending treatment for patients. Mediflow scans keywords of a healthcare professionals input and compares it to an indexed database utilizing both Heuristic and Boolean logical algorithms.   The software compares the disease database looking for matching symptoms, analyzes the true phase (during current treatment), and the medications or other treatments being used.  It then matches the results with models found in the database, flaggingany abnormalities in both the diagnosis and treatment, and suggesting a solution.



2

MediFlow has the capability to also provide third-party specialists with HIPAA-compliant access to patient information for their review and recommendations.   Access can be provided through the interactive use of text, audio, pictures or video both encapsulated and streaming; currently, the software supports both Audio and Visual access through .wav files, allowing it to also interface with third party software to make these features functional.



Software functionality is dependent on the accurate input of patient data. Software gateways are open to add modules to and for database integration, by permitting searches of the healthcare professionals database and third-party databases. We may lease or acquire a third party data base to improve existing functionality for marketing purposes.  At present, costs associated with such lease or acquisition is not known. We plan to market our software as a service to Doctors and other health professionals in the U.S. and Canada.  We plan to further develop our software program as an easy to use, functional, responsive and integrated program that focuses on the needs of the Heath Care community.

Plan of Operation



Financial Plan

As of March 31, 2008 we had a cash balance $30 and have earned no revenue from operations. Since our inception on April 14, 2004 to March 31, 2008 we have raised $92,650 in equity financing via distributions of unregistered securities to Canadian investors using exemptions provided under Regulation S and under British Columbia, Alberta and Saskatchewan Multilateral Instrument 45-103 Part 2 in Canada. During the next twelve months we will need additional funds and we are seeking these additional funds via, private placements or loans from our sole officer and director or current shareholders or potentially an initial public offering. No arrangements for additional funds have been completed.

Software Development Plan

We have commenced the process of upgrading the existing software code and will need additional financing to complete these upgrades. We estimate the cost of this initial upgrade to be $50,000. We are pursuing additional funding in order to complete our upgrades. To date we have accomplished the following tasks with respect to the upgrade of our software. We have extensively tested the current software, we have analyzed and targeted areas in the original source code for upgrades, these areas include, the installation program, database, the programs compiler, additionally, there is no uninstall program in our current version of the program so any data or files have to be deleted manually from the program. As an additional upgrade we would add in an uninstall program. We anticipate commencing these upgrades in March or April 2008 and are currently in the process of scheduling programming time with a qualified programmer.













3







Website Development Plan

The development of our website was initially completed during April of 2007. The Company briefly had their website operational, but the site did incur technical difficulties with respect to their software program being able to operate within in a web browser. The Company is currently and still working at rectifying these difficulties and anticipate having a temporary site posted in March 2008.

Our website address on the Internet at www.medi-flow.com

Website Hosting Plan

Our website will be hosted by Network Solutions and will be charging us approximately $15 per month to host our website. Over the next twelve months the cost of hosting our website will be $180

Marketing Plan

We plan to undertake the development of a logo and other art

and to develop a look and feel for our brochures and web site and

that we will incorporate into an advertising and marketing campaign.  We anticipate that initial marketing expenses, including travel for the first year will be approximately $75,000.  We anticipate that the marketing materials and campaign would be designed by an outside marketing consulting firm.

Accounting and Audit Plan

We intend to continue to have our outside consultant assist in the preparation of our quarterly and annual financial statements and have these financial statements reviewed or audited by our independent auditor. Our outside consultant charges us $1,000 to assist in the preparation of our quarterly financial statements and $2,500 to assist in the preparation of our annual financial statements. Our independent auditor charges us approximately $2,000 to review our quarterly financial statements and approximately $7,500 to audit our annual financial statements. In the next twelve months, we anticipate spending approximately $18,500 to pay for our accounting and audit requirements.

SEC Filing Plan

We have become a reporting company in 2007. Our SB-2 was declared effective on June 8, 2007. This means that we will file documents with the US Securities and Exchange Commission on a quarterly basis. We expect to incur filing costs of approximately $650 per quarter to support our quarterly and annual filings. In the next twelve months, we anticipate spending approximately $5,000 for legal costs to pay for three quarterly filings, one annual filing.

Currently, we do not have any financing arrangements in place and there is no assurance that we will be able to achieve sufficient financing required to proceed with our plan of operation. If we do not obtain the necessary financing, then our plan of operation will be scaled back according to the amount of funds available. Our inability to raise the necessary financing may restrict our ability to complete product development and market our product.







4









RESULTS OF OPERATIONS Third Quarter Summary





|9 Months Ended March 31 |           |          |  | 
|----------------------- | --------- | -------- |  | 
|                        |           |          |  | 
|                        | 2008      | 2007     |  | 
|Revenue                 | $Nil      | $Nil     |  | 
|Expenses                | (7,996)   | (4,123)  |  | 
|Net Income (Loss)       | $((7,996) | $(4,123) |  | 





Revenues

We have not earned any revenue to date and we do not anticipate earning revenue until we have completed commercial development and upgrades of our Mediflow software program. We are presently in the development stage of our business and we can provide no assurance that we will be able to complete commercial development or successfully sell or license products incorporating our Mediflow software program, once development upgrades are complete.

Operating Costs and Expenses

Our expenses increased by $3,873 during the nine-month period ended March 31, 2008 over the same period ended March 31, 2007 This increase is primarily the result of professional fees associated with being a reporting issuer.

In accordance with SEC Staff Accounting Bulletin Topics 1:B and 5:T, we are required to report all costs of conducting our business.. For the nine months ended March 31, 2008, we recorded contributed executive services expenses of $.0 of services that were provided to us without charge.

Subject to our ability to obtain additional financing, of which there is no assurance, we expect that our product and business development activities will continue to increase over the course of the current fiscal year. As such, we expect that our operating expenses will also continue to increase at a significant rate.

We anticipate our operating expenses will increase as we undertake our plan of operations and continue to implement our business plan. The increase will be attributable to increased product and business development activities and the professional fees associated with complying with our reporting obligations under the Securities Exchange Act of 1934 (the Exchange Act).









5

LIQUIDITY AND CAPITAL RESOURCES

|Working Capital                                                 |                   |                        |  |  | 
|--------------------------------------------------------------- | ----------------- | ---------------------- |  |  | 
|                                                                |                   |                        |  |  | 
|                                                                | At March 31, 2008 | At June       30, 2007 |  |  | 
|Current Assets                                                  | $30               | $8,026                 |  |  | 
|Current Liabilities                                             | 7,500             | $7,500                 |  |  | 
|Working Capital (Deficit)                                       | (7,470)           | 526                    |  |  | 
|Cash Flows                                                     
|Nine Months Ended March 31                                     
|2008
2007                                                      
|Cash Flows from (used in) Operating Activities
$(7,996)
(4,123)
|Cash Flows from (used in) Investing Activities
--
--           
|Cash Flows from (used in) Financing Activities
$ 4,000
0       
|Net Increase (decrease) in Cash During Period
$(496)
(27,623)  

The decrease in our working capital deficit at March 31, 2008 as compared to our fiscal year ended June 30, 2007 is primarily a result of the fact that we had no sources of revenue and limited sources of financing during the period. As a result, we were required to use existing cash reserves in order to meet our obligations during the period. As of March 31, 2008, the date of our most recently available financial statements, we had cash on hand of $30. Since our inception, we have used sales of our common stock to raise money for our operations and for our acquisition. We have not attained profitable operations and are dependent upon obtaining financing to pursue our plan of operation.

We anticipate spending approximately $355,000 over the next twelve months in pursuing our plan of operation. This amount is in excess of our current working capital reserves and we have not earned any revenues to date and do not anticipate earning revenues until we have completed commercial development of our product. Accordingly, we will require additional financing in order to fund our plan of operation. We anticipate that any additional financing will likely be in the form of equity financing as substantial debt financing will not be as available at this stage of our business.

OFF-BALANCE SHEET ARRANGEMENTS

We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to our stockholders.











6



CRITICAL ACCOUNTING POLICIES

The financial statements presented with this Quarterly Report on Form 10-QSB have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information.

These financial statements do not include all information and footnote disclosures required for an annual set of financial statements prepared under United States generally accepted accounting principles. In the opinion of our management, all adjustments (consisting solely of normal recurring accruals) considered necessary for a fair presentation of the financial position, results of operations and cash flows as at March 31, 2008 and for all periods presented in the attached financial statements, have been included. Interim results for the three-month period ended March 31, 2008 are not necessarily indicative of the results that may be expected for the fiscal year as a whole.

We have identified certain accounting policies, described below, that are most important to the portrayal of our current financial condition and results of operations. Our significant accounting policies are disclosed in the notes to the consolidated financial statements included with this Quarterly Report on Form 10-QSB.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from these estimates.

Foreign Currency Translation

Transaction amounts denominated in foreign currencies are translated at exchange rates prevailing at transaction dates. Carrying values of monetary assets and liabilities are adjusted at each balance sheet date to reflect the exchange rate at that date. Non-monetary assets and liabilities are translated at the exchange rate on the original transaction date. Gains and losses from restatement of foreign currency monetary assets and liabilities are included in the statements of operations. Revenues and expenses are translated at the rates of exchange prevailing on the dates such items are recognized in the statement of operations.

Contributed Executive Services

Pursuant to SAB topic 1:B(1) and the last paragraph of SAB 5:T, we are required to report all costs of conducting our business. Accordingly, we record the fair value of contributed executive services provided to us at no cost as compensation expense, with a corresponding increase to additional paid-in capital, in the year which the services are provided.





7

RISK FACTORS

Need For Financing

We do not currently have the financial resources to complete our plan of operation for the next twelve months. We anticipate that we will require financing in the amount of $355,000 in order to fund our plan of operation over the next twelve months. We presently do not have any financing arrangements in place and there is no assurance that we will be able to obtain sufficient financing on terms acceptable to us or at all. If further financing is not available or obtainable, our ability to meet our financial obligations and pursue our plan of operation will be substantially limited and investors may lose a substantial portion or all of their investment.

Limited Operating History, Risks Of A New Business Venture

We were incorporated on April 14, 2004 and, prior to our acquisition of Mediflow, we had been involved primarily in organizational activities and in seeking business opportunities and products. We have not earned any revenues to date.

Potential investors should be aware of the difficulties normally encountered by a new enterprise and the high rate of failure of such enterprises. The potential for future success must be considered in light of the problems, expenses, difficulties complications and delays encountered in connection with the development of a business in the area in which we intend to operate and in connection with the formation and commencement of operations of a new business in general. These include, but are not limited to, unanticipated problems relating to research and development programs, marketing, approvals by government agencies, competition and additional costs and expenses that may exceed current estimates. There is no history upon which to base any assumption as to the likelihood that our business will prove successful, and there can be no assurance that we will generate any operating revenues or ever achieve profitable operations.

Our Business Operations, Assets and Personnel Are Located Outside The United States

Although we are incorporated in the United States, all of our current operating activities are conducted in, and all of our assets and personnel are located in, Canada. As such, investors in our securities may experience difficulty in enforcing judgments or liabilities against the Company or our personnel under United States securities laws.













8

Our corporate headquarters are located at 16 Midlake Boulevard, Suite 312 SE Calgary Alberta, Canada As we are a Nevada corporation, we are required to maintain a resident agent in the State of Nevada for the purpose of receiving service of process. Under Section 78.090 of the Nevada Revised Statutes, all legal process and any demand or notice authorized by law to be served upon the Company may be served upon our resident agent in Nevada. Our resident agent for this purpose is Nevada Agency and Trust 50 West Liberty Street, Suite 880 Reno Nevada 89501.



As a Nevada corporation, we are subject to the laws of the United States, including the federal securities laws of the United States, and to the jurisdiction of United States courts. As such, investors may bring proceedings against us, and enforce judgments obtained against us, in United States courts.



Generally, original actions to enforce liabilities under United States federal securities laws may not be brought in a Canadian court. Such actions must be brought in a court in the United States with applicable jurisdiction. Persons obtaining judgments against us in United States courts, including judgments obtained under United States federal securities laws, will then be required to bring an application in a Canadian court to enforce such judgments in Canada.



Competition Is Intense And We May Be Unable To Achieve Market Acceptance



The business environment in which we intend to operate is highly competitive. Currently, there exists a number of software products similar to ours and we expect to experience competition from a number of established companies involved in the software development industry. Certain of our potential competitors will have greater technical, financial, marketing, sales and other resources than us.



In addition, while the software development industry is a mature one, we are unable to provide assurances that our target customers and markets will accept our technologies or will purchase our products and services in sufficient quantities to achieve profitability. If a significant market fails to develop or develops more slowly than we anticipate, we may be unable to recover the losses incurred to develop products and we may be unable to meet our operational expenses. Acceptance of our products by companies and other organizations will depend upon a number of factors, including the cost competitiveness of our products, customer reluctance to try new products or services, or the emergence of more competitive or effective products.



Rapid Technological Changes  Could Make Our Product Obsolete



The software development industry is characterized by rapid technological change and intense competition. New technologies, products and industry standards will develop at a rapid pace which could make our planned products obsolete. Our future success will depend upon our ability to develop and introduce product enhancements to address the needs of customers. Material delays in introducing product enhancements may cause customers to forego purchases of our product and purchase those of competitors.





9

Dependence On Key Personnel

Our success will largely depend on the performance of our directors and officers and our key consultants. Our success will also depend on our ability to attract and retain highly skilled technical, research, management, regulatory compliance, sales and marketing personnel. Competition for such personnel is intense. The loss of the services of such personnel or the inability to attract and retain other key personnel could impair the development of our business, operating results and financial condition.

ITEM 3.                CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this report, our management carried out an evaluation, under the supervision and with the participation of our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on this evaluation, our principal executive officer and principal financial officer has concluded that our disclosure controls and procedures are, as of the date covered by this Quarterly Report, effective to ensure that the information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms.

Changes in Internal Controls Over Financial Reporting

In connection with the evaluation of our internal controls during our last fiscal quarter, our principal executive officer and principal financial officer has determined that there have been no changes to our internal controls over financial reporting that has materially affected, or is reasonably likely to materially effect, our internal controls over financial reporting.





















10

PART II - OTHER INFORMATION

ITEM 1.                LEGAL PROCEEDINGS.

None.

ITEM 2.               UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

ITEM 3.                DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4.                SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

None.

ITEM 5.                OTHER INFORMATION. Other Events

None

ITEM 6.                EXHIBITS AND REPORTS ON FORM 8-K.

Exhibit Number



Description of Exhibit











31.1

Certification of Chief Executive Officer and Chief Financial Officer as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.





32.1

Certification of Chief Executive Officer and Chief Financial Officer as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.















REPORTS ON FORM 8-K

The Company filed Current Reports on Form 8-K during the fiscal quarter ended March 31, 2008, on  January 24, 2008











SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.







(QV) QUANTUM VENTURES, INC.

















Date: May 14, 2007

By: /s/Desmond Ross







Desmond Ross







Chief Executive Officer, Chief Financial Officer







President, Director (Principal Executive Officer







and Principal Accounting Officer)